World-first robo surgeon rolls out from Mac Park

Australia is one of the first countries in the world to deploy new state-of-the-art robotic technology used in knee replacement surgery.

Johnson & Johnson Medical Australia, based in Macquarie Park, have announced the release following its inclusion on the Australian Register of Therapeutic Goods.

Sue Martin, Managing Director of Johnson & Johnson Medical Australia and New Zealand says:

“Australia joins an exclusive list of just a few countries with access to this technology to date.”

“The introduction of the VELYS Robotic-Assisted Solution is testament to Johnson & Johnson Medical Device’s ongoing commitment to create innovative technologies that help hospitals and surgeons improve patient outcomes and advance the sustainability of Australia’s healthcare system.”

There were 65,266 knee replacement surgeries in 2018 according to the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR 2019).

New technology development is one of the best tools the healthcare industry has to innovate and improve patient care.

Although robotics have been used to assist surgeons for some time, the VELYS™ Robotic-Assisted Solution overcomes challenges by adapting to the surgeon’s workflow and employing advanced planning capabilities.

The robotic medtech is accompanied by a first-of-its-kind mobile training lab, that takes innovative training solutions - including virtual reality, 3D printed models and digital simulations - to surgeons across the country.

Housed inside an articulated semi-trailer, the mobile lab recently hit the road and will begin visiting surgeons in situ across Australia soon.